Frederick G. Vogt - Interim CEO & General Counsel, Director at Iovance Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO & General Counsel, Director
Stock Symbol
IOVA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Frederick G. Vogt since 9/19/2023

Holdings reported by Frederick G. Vogt for Iovance Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 192K $2.09M $10.85 Sep 3, 2024 Direct
Restricted Stock Units 46.9K $509K $10.85 Sep 3, 2024 Direct Common Stock

Transactions reported by Frederick G. Vogt for Iovance Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.